Managing pregnancy with HIV, HELLP syndrome and low platelets

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Maternal-Fetal Medicine

Background:

• Pregnancies complicated by human immunodeficiency virus (HIV) and HELLP syndrome (haemolytic anaemia, elevated liver enzymes, low platelets) present diagnostic and therapeutic challenges.
• Low platelet counts are common in severe pre-eclampsia, eclampsia, and HELLP syndrome, necessitating early identification.

Purpose of the Study:

• To outline the complexities in managing pregnancies with HIV and HELLP syndrome.
• To emphasize the importance of early detection and appropriate management of low platelets in pregnancy.

Main Methods:

• Review of current management strategies for HELLP syndrome and associated conditions.
• Discussion of diagnostic considerations for isolated thrombocytopenia in pregnancy.
• Evaluation of treatment options including antihypertensives, anticonvulsants, steroids, and platelet transfusions.

Main Results:

• Standard treatment for HELLP syndrome involves blood pressure control, seizure prevention (MgSO4), steroids for fetal lung maturity, and delivery.
• High-dose steroids for rapid platelet recovery in HELLP syndrome are controversial and not routinely recommended.
• Platelet transfusions are a temporary measure, indicated only in severe cases with bleeding or before surgery.

Conclusions:

• Low platelets in pregnancy warrant thorough investigation, potentially indicating HELLP syndrome, HIV, or other conditions like gestational thrombocytopenia.
• Gestational thrombocytopenia is a benign diagnosis of exclusion.
• Clinicians must be aware that isolated low platelets can be an early sign of HIV infection.